Clinical Trials
361 trialsA Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Memorial Sloan Kettering Cancer Center
Infectious Complications in Hematological Patients Under Treatment With Bispecific Antibodies.
Infanta Leonor University Hospital
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
M.D. Anderson Cancer Center
Biomarker for Infection Risk in CLL and MM
Massachusetts General Hospital
COSMIC
ASH Research Collaborative
Towards Effective, Patient-tailored Anti-plasma Cell Therapies in AL Amyloidosis: Predicting Drug Response and Overcoming Drug Resistance
Fondazione IRCCS Policlinico San Matteo di Pavia
Anonymization of Clinical Data From Pseudonymized Databases Collected as Part of Previus Clinical Trials on Multiple Myeloma
IRCCS Azienda Ospedaliero-Universitaria di Bologna
MMAPPIN' Study: Multiple Myeloma Analysis For Patient-specific Insights to Dissect Disease Heterogeneity
IRCCS Azienda Ospedaliero-Universitaria di Bologna
LONGEVITI
University of Alberta
iPREFER
The Christie NHS Foundation Trust
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Dana-Farber Cancer Institute
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
Dana-Farber Cancer Institute
ALPS
Fondazione IRCCS Policlinico San Matteo di Pavia
Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
Dana-Farber Cancer Institute
iCaRe2
University of Nebraska
RISE
Gruppo Italiano Malattie EMatologiche dell'Adulto
COGNITOX
University of Aarhus
VAMOS
University Hospital, Toulouse
CER
Cancer Support Community, Research and Training Institute, Philadelphia
Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
M.D. Anderson Cancer Center
ReAL
Fondazione IRCCS Policlinico San Matteo di Pavia
EUREKA
Fondazione IRCCS Policlinico San Matteo di Pavia
ProDigALIty
Fondazione IRCCS Policlinico San Matteo di Pavia
Pre-malignant States to Hematologic Malignancies in Firefighters
Wake Forest University Health Sciences
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
M.D. Anderson Cancer Center
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Wake Forest University Health Sciences
TRANSFORMM
University of Miami
Study of CAR-T Therapy in Older Patients
Memorial Sloan Kettering Cancer Center
Predicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study
Shanxi Bethune Hospital
Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma
The First Hospital of Jilin University
ITA-WebNet
Fondazione IRCCS Policlinico San Matteo di Pavia
Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma
Shanxi Bethune Hospital
B-SCR-MM
Ohio State University Comprehensive Cancer Center
MED-hATTR
The Cleveland Clinic
Rapid dFLC Response Predict CHR in AL Amyloidosis
Peking University People's Hospital
Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
University of Chicago
GlycAL
Fondazione IRCCS Policlinico San Matteo di Pavia
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant
H. Lee Moffitt Cancer Center and Research Institute
Biomarkers of AKI in Patients Receiving Daratumumab
Brigham and Women's Hospital
BE.Amycon Biobank & Data Registry UZ Leuven
Universitaire Ziekenhuizen KU Leuven
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
City of Hope Medical Center
A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders
Memorial Sloan Kettering Cancer Center
SPOTLIGHT
University of Utah
Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers
M.D. Anderson Cancer Center
AI
Zhongnan Hospital
NICHE
Institute of Hematology & Blood Diseases Hospital, China
DynaFiT
The First Hospital of Jilin University
GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma
Fundación Española de Hematología y Hemoterapía
Validating Fish Oil's Role in Alleviating Bortezomib-Induced Neuropathy: A Multi-Method Study Integrating Big Data, Experimental, and Clinical Research
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission
Memorial Sloan Kettering Cancer Center